These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 24051136)

  • 1. Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats.
    Grupe M; Paolone G; Jensen AA; Sandager-Nielsen K; Sarter M; Grunnet M
    Biochem Pharmacol; 2013 Nov; 86(10):1487-96. PubMed ID: 24051136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors.
    Grupe M; Jensen AA; Ahring PK; Christensen JK; Grunnet M
    Br J Pharmacol; 2013 Apr; 168(8):2000-10. PubMed ID: 23278456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.
    Parikh V; Ji J; Decker MW; Sarter M
    J Neurosci; 2010 Mar; 30(9):3518-30. PubMed ID: 20203212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex.
    Parikh V; Man K; Decker MW; Sarter M
    J Neurosci; 2008 Apr; 28(14):3769-80. PubMed ID: 18385335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
    Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
    J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct allosteric binding sites at α4β2 nicotinic acetylcholine receptors revealed by NS206 and NS9283 give unique insights to binding activity-associated linkage at Cys-loop receptors.
    Olsen JA; Kastrup JS; Peters D; Gajhede M; Balle T; Ahring PK
    J Biol Chem; 2013 Dec; 288(50):35997-6006. PubMed ID: 24169695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors.
    Timmermann DB; Sandager-Nielsen K; Dyhring T; Smith M; Jacobsen AM; Nielsen EØ; Grunnet M; Christensen JK; Peters D; Kohlhaas K; Olsen GM; Ahring PK
    Br J Pharmacol; 2012 Sep; 167(1):164-82. PubMed ID: 22506660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats.
    Mohler EG; Franklin SR; Rueter LE
    Psychopharmacology (Berl); 2014 Jan; 231(1):67-74. PubMed ID: 23925734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
    J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.
    Rode F; Munro G; Holst D; Nielsen EØ; Troelsen KB; Timmermann DB; Rønn LC; Grunnet M
    Brain Res; 2012 Jun; 1458():67-75. PubMed ID: 22552114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.
    Wang J; Kuryatov A; Sriram A; Jin Z; Kamenecka TM; Kenny PJ; Lindstrom J
    J Biol Chem; 2015 May; 290(22):13907-18. PubMed ID: 25869137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Potentiation of the (α4)
    Appiani R; Viscarra F; Biggin PC; Bermudez I; Giraudo A; Pallavicini M; Bolchi C
    ACS Chem Neurosci; 2024 Apr; 15(7):1501-1514. PubMed ID: 38511291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms.
    Howe WM; Ji J; Parikh V; Williams S; Mocaër E; Trocmé-Thibierge C; Sarter M
    Neuropsychopharmacology; 2010 May; 35(6):1391-401. PubMed ID: 20147893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.
    Mazzaferro S; Bermudez I; Sine SM
    Cell Mol Life Sci; 2019 Mar; 76(6):1151-1167. PubMed ID: 30600358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
    Hamouda AK; Bautista MR; Akinola LS; Alkhlaif Y; Jackson A; Carper M; Toma WB; Garai S; Chen YC; Thakur GA; Fowler CD; Damaj MI
    Neuropharmacology; 2021 Jun; 190():108568. PubMed ID: 33878302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological modulation of the P3-like event-related potential in a rat two-tone auditory discrimination task with modafinil and NS9283, a positive allosteric modulator of α4β2 nAChRs.
    Grupe M; Grunnet M; Laursen B; Bastlund JF
    Neuropharmacology; 2014 Apr; 79():444-55. PubMed ID: 24361451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic α4β2 Cholinergic Receptor Influences on Dorsolateral Prefrontal Cortical Neuronal Firing during a Working Memory Task.
    Sun Y; Yang Y; Galvin VC; Yang S; Arnsten AF; Wang M
    J Neurosci; 2017 May; 37(21):5366-5377. PubMed ID: 28450546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex.
    Livingstone PD; Srinivasan J; Kew JN; Dawson LA; Gotti C; Moretti M; Shoaib M; Wonnacott S
    Eur J Neurosci; 2009 Feb; 29(3):539-50. PubMed ID: 19187266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
    Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
    Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.